Market Overview

UPDATE: Piper Jaffray Reiterates Overweight Rating, Raises PT on Cerner Corporation on Q4 Bookings

Share:
Related CERN
Earnings Scheduled For August 4, 2015
Cerner to Replace Department of Defense's Anatomic Pathology Laboratory Information System
Stocks Set For Lower Start; Regeneron Jumps On Earnings (Investor's Business Daily)

In a report published Wednesday, Piper Jaffray reiterated its Overweight rating on Cerner Corporation (NASDAQ: CERN), and raised its price target from $84.00 to $100.00.

Piper Jaffray noted, “Cerner reported numbers that beat our and consensus estimates handily. Bookings of $1.02 billion was the highlight in the quarter, exceeding its own guidance despite not adding a single ITWorks and RevWorks contract. While the stimulus rush is helping the bookings growth right now, we believe the company is already establishing itself in data analytics, which is the next growth leg in Healthcare IT. We believe that healthcare data analytics is a huge developing market with very limited competition and early glimpses of the capabilities suggests that CERN will become a dominant player."

Cerner Corporation closed on Tuesday at $83.60.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2015OppenheimerInitiates Coverage onOutperform
Apr 2015SunTrust Robinson HumphreyDowngradesBuyNeutral
Apr 2015BarclaysMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

Get Benzinga's Newsletters